The rapidly evolving COVID-19 public health crisis is impacting every community across theRead more
Drug Pricing
Securing Affordable Treatments for All Americans
Left unchecked, the pharmaceutical industry continues to set exorbitant drug prices and hinder competition in the marketplace. ACHP advocates for policies that promote reasonable prescription drug prices and ensure a sustainable health care system that works for patients and health plans alike. ACHP is dedicated to cracking down on anticompetitive practices, spurring development of generic and biosimilar treatments and increasing transparency around price setting.
To the Point
-
03/05/2020
OP-ED — We Must Win the War on Drug Pricing if We Want to Win the War on Cancer
We may be winning battles against cancer. But we will lose the war if we don’t do something about the rising cost of drugs in the United States. -
03/06/2020
FACT SHEET — Support Legislation to Reduce Drug Prices
Legislation can help check drug makers ability to hike prices and inject more competition into the market — helping lower prices for all. -
04/08/2019
INFOGRAPHIC — A Unique Approach: Transparent PBMs
ACHP member health plans run fully transparent, fee-based PBMs that keep drug costs in check. -
10/05/2018
INFOGRAPHIC — Biosimilars: An Antidote For High Prices
Millions struggle to pay high drug prices, forcing them to choose either medication or other expenses. Our infographic explains how “biosimilars” can help.
Deep Dive
-
04/07/2020
LETTER — Medicare Part C-D Regulations, 2020
ACHP's comments in response to the proposed rule on Medicare Advantage and Part D for the Contract Year 2021 and 2022. -
12/17/2019
RELEASE — ACHP statement on House passage of 2020 appropriations legislation
Passing the bipartisan CREATES Act is a key step in discouraging anticompetitive behavior, removing barriers to competition for generics and providing consumers relief.
Problem/Solution
PROBLEM: Current law unintentionally prevents most seniors in high-quality MA plans from receiving expanded benefits, reduced premiums and/or lower co-pays. Counties across the country are hurt by a limit known as the MA benchmark cap. It is unfair to penalize seniors based on where they live.
SOLUTION: Congress can remedy this by paying full MA quality bonuses. The Medicare Advantage Quality Payment Relief Act (S. 1114, H.R. 2131) ensures seniors enrolled in high quality MA plans receive full benefits and are not hurt by the cap. Learn more here.
Resource Library Search
INFOGRAPHIC — Breakdown of Changes in Consumers’ Health Care Behavior During COVID-19
The ongoing COVID-19 public health crisis is causing an unprecedented shift in theRead more
BLOG — A Call for Swift Congressional Action on COVID-19
Millions of Americans who have lost employment and health coverage due to COVID-19 are depending on additional Congressional action.
LETTER — ACHP Urges Senate Leaders to Pass Additional COVID-19 Relief
ACHP urges the Senate to consider additional legislation to respond to the unprecedented public health and economic crisis caused by the COVID-19 pandemic.
NEWSLETTER — Community Health Plans: Prioritizing Value
ACHP plans are standing with their provider partners, providing critical support to help ensure continued access to essential care.